Condition: Prostate Cancer · Pain Cancer · Sponsor: Deventer Ziekenhuis
Prostate cancer often leads to bone metastases, which require adequate pain management with opioids such as oxycodone. This study investigates whether abiraterone - a drug used in the treatment of prostate cancer - affects the pharmacokinetics of oxycodone in order to improve pain management.
This description comes directly from the study's public registry record.
Frank Jansman, Prof. dr. · +31570 53 60 00 · f.jansman@dz.nl
Lotte Hulskotte, drs. · +31631451719 · l.hulskotte@dz.nl
Always discuss trial participation with your own doctor first.
| Deventer Ziekenhuis | Deventer, Overijssel, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07001709